1-3 of 3
Uma Mudunuru
Close
Sort by
Journal Articles

Targeting Mutant Nucleophosmin 1 (NPM1) Induces Differentiation, Loss of Survival and Sensitizes AML Cells to All-Trans Retinoic Acid, Cytarbine and FLT3 Antagonists

Ramesh Balusu, PhD, Josiah Cox, Stacey Hembruff, MS, Warren Fiskus, BSc, PhD, Rekha Rao, PhD, Uma Mudunuru, MS, Ruben Reyes, MD, Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Heather Male, MD, Allan Fleming, MD, Casey B Williams, Pharm.D., Joseph McGuirk, DO, Kapil N. Bhalla, MD
Journal: Blood
Blood (2011) 118 (21): 733.
https://doi.org/10.1182/blood.V118.21.733.733
Published: 2011
Journal Articles

Treatment with β-Catenin Antagonist BC2059 Exerts Single Agent Efficacy and Exerts Improved Activity with Tyrosine Kinase Inhibitor (TKI) or Pan-Histone Deacetylase (HDAC) Inhibitor Against Human CML and Myeloproliferative Neoplasm (MPN) Progenitor Cells

Warren Fiskus, PhD, Jacqueline Smith, MS, Uma Mudunuru, MS, Stacey Hembruff, MS, Ruben Reyes, MD, Sunil Abhyankar, MD, Joseph McGuirk, DO, Omar S. Aljitawi, MD, Siddhartha Ganguly, MD, Stephen K. Horrigan, PhD, Sunil Sharma, MD, Kapil N. Bhalla, MD
Journal: Blood
Blood (2011) 118 (21): 65.
https://doi.org/10.1182/blood.V118.21.65.65
Published: 2011
Journal Articles

Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1

Ramesh Balusu, Warren Fiskus, Rekha Rao, Daniel G. Chong, Srilatha Nalluri, Uma Mudunuru, Hongwei Ma, Lei Chen, Sreedhar Venkannagari, Kyungsoo Ha, Sunil Abhyankar, Casey Williams, Joseph McGuirk, Hanna Jean Khoury, Celalettin Ustun, Kapil N. Bhalla
Journal: Blood
Blood (2011) 118 (11): 3096–3106.
https://doi.org/10.1182/blood-2010-09-309674
Published: 2011
Includes: Supplemental data